Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locallyadvanced prostate cancer
- 1 April 2003
- journal article
- clinical trial
- Published by Elsevier BV in Urology
- Vol. 61 (4), 774-780
- https://doi.org/10.1016/s0090-4295(02)02519-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Neoadjuvant estramustine and etoposide followed by concurrent estramustine and definitive radiotherapy for locally advanced prostate cancer: Feasibility and preliminary resultsInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Adjuvant and neoadjuvant therapy in prostate cancerSeminars in Oncology, 2001
- Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancerUrology, 2001
- Results of a Phase II Study Using Estramustine Phosphate and Vinblastine in Combination With High-Dose Three-Dimensional Conformal Radiotherapy for Patients With Locally Advanced Prostate CancerJournal of Clinical Oncology, 2000
- Neoadjuvant Chemotherapy and Hormonal Therapy Followed by Radical Prostatectomy: Feasibility and Preliminary ResultsJournal of Clinical Oncology, 2000
- 4–Year Follow–Up Results of a European Prospective Randomized Study on Neoadjuvant Hormonal Therapy prior to Radical Prostatectomy in T2–3N0M0 Prostate CancerEuropean Urology, 2000
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999
- Randomized, Prospective, Controlled Study Comparing Radical Prostatectomy Alone and Neoadjuvant Androgen Withdrawal in the Treatment of Localized Prostate CancerJournal of Urology, 1996
- Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate CancerJournal of Urology, 1995
- The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate CancerJournal of Urology, 1993